Completed PHASE2 INTERVENTIONAL 1-arm NCT00849147

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

A Multi-Center, Phase II Trial of Nonmyeloablative Conditioning (NST) and Transplantation of Partially HLA-Mismatched Bone Marrow From Related Donors for Patients With Hematologic Malignancies (BMT CTN #0603)

Sponsor: Blood and Marrow Transplant Clinical Trials Network

Conditions Burkitt Lymphoma Leukemia, Myeloid, Acute Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Interventions GVHD prophylaxis Haploidentical Bone Marrow Transplantation

Updated 9 times since 2017 Last updated: Dec 7, 2022 Started: Oct 31, 2008 Primary completion: Jun 30, 2011 Completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Burkitt Lymphoma and Leukemia, Myeloid, Acute and is currently completed. Blood and Marrow Transplant Clinical Trials Network leads this study, which shows 9 recorded versions since 2008 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Feb 2023 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Feb 2023 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2018 — Jun 2018 [monthly]

Completed PHASE2
Feb 2017 — Jan 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Blood and Marrow Transplant Clinical Trials Network
Medical College of Wisconsin
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
National Marrow Donor Program

Data source: Medical College of Wisconsin

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Baltimore, United States , Boston, United States , Charleston, United States , Dallas, United States , Detroit, United States , Duarte, United States , Gainesville, United States , Honolulu, United States , La Jolla, United States and 6 more locations